Control,hemoglobin
Open Solicitation Posted
- Solicitation number
- SPE2DS27T1385
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- Not on record
- More information
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical Supply Chain seeks quotes for two boxes of CONTROL,HEMOGLOBIN (NSN 6550-01-722-4549) under request for quotation SPE2DS27T1385, with quotes due November 9, 2026 via DIBBS. The procurement is unrestricted, with no set-aside used, and uses Fast Auto Evaluation.
Delivery is required within five days to USS Makin Island LHD 8 at FPO AP 96672, on FOB destination terms with inspection at destination and zero percent quantity variance permitted. Quoters are encouraged to submit quantity ranges because of demand volatility. The product is an FDA-regulated Class II device requiring registration, listing, labeling, and Good Manufacturing Practice compliance, with a 24-month shelf life, no more than three months from manufacture to delivery, and refrigerated storage at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit). Packaging must be commercial and suitable for safe delivery in sealed containers.
Compliance obligations include the Buy American Act, the Berry Amendment (reduced to a $150,000 threshold), and domestic material restrictions. Applicable DFARS clauses cover telecommunications equipment restrictions, export controls, hazardous material handling, sea transport on U.S.-flag vessels, and cybersecurity. Marking must follow Medical Marking Standard No. 1, which replaces MIL-STD-129. The solicitation incorporates the DLA Master Solicitation for Automated Simplified Acquisitions (Revision 105, May 20, 2026). Micro-purchase quotes may be awarded before the return date, and the solicitation may be a candidate for automated award unless first article test requirements apply.
Recent awards for this item went to CAGE codes 4QNY3, 0AG09, and 1WAS9 at unit costs of $54.79 to $71.77 between July 2025 and October 2026. The PSC is 6550, In Vitro Diagnostic Substances, Reagents, Test Kits And Sets.
Notice text
DLA request for quotation SPE2DS27T1385, issued by DLA office SPE2DS through DIBBS. Quotes are due by 11/09/2026. Set-aside: No Set-Aside Used. Solicitation type: Fast Auto Evaluation. FOB Destination. Inspection at Destination. Item: line 0001, CONTROL,HEMOGLOBIN, NSN 6550-01-722-4549, 2 BX, delivery in 5 days, PR 7018973434. Quotes must be submitted via DIBBS.
Files
| File | Type | Posted |
|---|---|---|
| SPE2DS27T1385.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Control,blood chemist | Medical Supply Chain | No set-aside | |
| Control,blood chemist | Medical Supply Chain | No set-aside | |
| Control set,blood CHE | Medical Supply Chain | No set-aside | |
| Control,glucose | Medical Supply Chain | No set-aside | |
| Control set,human SER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity